Internal Medicine Doctors in St Johnsbury, VT Accepting Medicare

5 Internal Medicine doctors found. Showing 1 - 5

Patrick Heaghney, M.D. Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 165 Sherman Dr, St Johnsbury, VT 05819 Phone: 802-748-9405

Thomas Frank Ziobrowski, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 714 Breezy Hill Rd, St Johnsbury, VT 05819 Phone: 802-748-7500    Fax: 802-745-1188

Frank J Meierdiercks, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 714 Breezy Hill Rd, St Johnsbury, VT 05819 Phone: 802-748-7500    Fax: 802-745-1188

Dr. Kenneth S. Danielson, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1290 Hospital Dr, St Johnsbury, VT 05819 Phone: 802-748-2984

Mr. Alfred J Barber, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 185 Sherman Dr, Suite 1, St Johnsbury, VT 05819 Phone: 802-748-5041    Fax: 802-748-5094

News Archive

HS6ST2 enzyme an important regulator of breast cancer cell-bone interactions

Researchers from VTT Technical Research Centre of Finland have in collaboration with the University of Turku, Indiana University and two Finnish companies, Biotie Therapies Corp. and Pharmatest Services Ltd, discovered a novel mechanism regulating the development of breast cancer bone metastases and showed that heparin-like compounds can potentially be used to inhibit breast cancer metastasis to bone.

Encouraging interim results from daclatasvir Phase IIb study in genotype 1 and 4 HCV patients

Bristol-Myers Squibb Company today announced interim results from a Phase IIb clinical trial (COMMAND-1) of 395 treatment-naïve, genotype 1 and 4 hepatitis C infected patients in which two doses of the investigational NS5A replication complex inhibitor daclatasvir (BMS-790052), in combination with peginterferon alfa and ribavirin (alfa/RBV), achieved higher virologic response rates through Week 12 than the alfa/RBV control group, with comparable rates of adverse events.

Amedica, Spinal Kinetics sign strategic agreement for silicon nitride spinal interbody fusion devices

Amedica Corporation, a biomaterial company that has developed silicon nitride ceramics as a material platform to manufacture and commercialize orthopaedic implants, is pleased to announce that it has entered into a multi-year private labeling agreement with Spinal Kinetics, a leading innovator of advanced artificial spinal disc technology.

Emergence of community-acquired infections due to ESBL-producing bacteria on the rise

The emergence of community-acquired infections, such as urinary tract infections (UTI), due to strains resistant to common antibiotics are on the rise, according to Rhode Island Hospital researchers. The study is published online in the journal Antimicrobial Resistance and Infection Control.

Viewpoints: 'Real' Medicare cuts?; HIV/AIDS prevention push; contraceptive coverage

Well, not really. A primer on the debt deal's health-care bookkeeping. All politicians—but these days especially Democrats—like to pretend they'll pay providers somewhat less in the future, despite knowing that is unlikely to happen in practice. Medicare's prospective payments are low enough that further reductions may jeopardize access to care and in many cases threaten the viability of hospitals and physician practices.

Read more Medical News

› Verified 1 days ago